Trump, Pfizer and White House

Trump Introducing Pfizer CEO Sparks Loud Booing Inside White House
A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of January 2025.
Trump giggles as White House crowd brutally boos head of Pfizer being introduced
The CEO of Pfizer was brutally booed at a press conference Donald Trump held in the White House in commemoration of Black History Month in an awkward moment that involved several similar introductions
So awkward: Trump introduces Pfizer CEO at intimate White House event and LOUD boos fill the room
Pfizer CEO Dr. Albert Bourla was loudly booed during a White House Black History Month event where he was introduced by President Trump.
Pfizer Exec Booed During White House Appearance as Trump Calls Pharma Head 'Great Businessman'
President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.
Greek-American Pfizer CEO Albert Bourla booed at White House event
Greek-American Pfizer CEO Dr Albert Bourla faced an unwelcoming reception at the White House during an event celebrating Black History Month, as some attendees jeered when former U.S. President Donald Trump introduced him.
Video: Head of Pfizer booed by Trump supporters
Head of Pfizer booed by Trump supporters At a Black History Month reception in Washington, DC, Trump shouted out the head of Pfizer, Albert Bourla, who was met with relentless booing. #news #trump #pfizer #politics #blackhistorymonth #washingtondc Daily Mail Website: Daily Mail Facebook: Daily Mail IG: Daily Mail
STAT1d
An awkward moment for Pfizer’s Bourla in Washington
The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...
BioSpace2d
Newly Stacked PhRMA to Meet With Trump on IRA, Other Policies
The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...
Should You Pick PFE Stock At $25?
Since the beginning of 2024, PFE stock has underperformed the S&P 500 index, delivering -3% returns compared to the index’s ...